ACHC — Acadia Healthcare Cashflow Statement
0.000.00%
Last trade - 00:00- $2.04bn
- $4.05bn
- $3.15bn
- 50
- 97
- 24
- 58
Annual cashflow statement for Acadia Healthcare, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -669 | 196 | 280 | -15.7 | 264 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 941 | 104 | 35.6 | 433 | 53.8 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 163 | -43.5 | -69.4 | 6.63 | -406 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | 584 | 374 | 381 | 462 | 130 |
| Capital Expenditures | -225 | -245 | -296 | -424 | -690 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -56.9 | 1,258 | -9.68 | 26.9 | -46.1 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -282 | 1,013 | -306 | -397 | -736 |
| Financing Cash Flow Items | -25.6 | 4.38 | 2.69 | -46.4 | -0.651 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -51.5 | -1,637 | -111 | -62.7 | 583 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 255 | -245 | -36.2 | 2.42 | -23.8 |